2014 Diagnostic Radiopharmaceuticals 
AuntMinnie
APRIL 4, 2024
Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.
Imaging Technology
JULY 9, 2024
Campione also joins the Blue Earth Diagnostics Ltd. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Board of Directors and will serve as Vice Chair of the Blue Earth Diagnostics Inc. Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., Board of Directors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 20, 2024
To establish which of the two is the optimal first-line approach, the group enrolled 57 patients (63 years old on average; 15 men and 42 women) in a multicenter randomized diagnostic intervention trial. Additionally, the tracer was found useful in 2014 in patients with PHPT. The full study is available here.
AuntMinnie
OCTOBER 25, 2024
He earned his medical degree at the University of Alabama School of Medicine and completed a residency in diagnostic radiology at the University of Florida. An assistant professor of radiology and radiological science, Francis Deng, MD, is the Johns Hopkins radiology department's co-director of medical student diagnostic radiology electives.
Imaging Technology
JUNE 10, 2024
For over three decades, Anderson’s pioneering research has laid the foundation for the growth of radiometal-based agents for diagnostic imaging and targeted radionuclide therapy of cancer, a field now known as "theranostics." Louis , Missouri, where she worked more than 20 years developing PET and radiopharmaceutical therapy agents.
AuntMinnie
JUNE 10, 2024
As president, I will continue to work to support the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, which will ensure equitable access to care and treatment for patients.”
Imaging Technology
JUNE 12, 2024
As president, I will continue to work to support the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 , which will ensure equitable access to care and treatment for patients.” Cutler is a member of the European Association of Nuclear Medicine , the Society of Radiopharmaceutical Sciences , and the American Chemical Association.
Expert insights. Personalized for you.
238 
Let's personalize your content